Imipramine Hydrochloride

Basic Information

Item Value
DrugBank ID DB00458
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 24

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 attention deficit-hyperactivity disorder KG + DL
2 attention deficit hyperactivity disorder, inattentive type KG + DL
3 faciodigitogenital syndrome KG + DL
4 specific developmental disorder KG + DL
5 chondromyxoid fibroma KG + DL
6 benign paroxysmal torticollis of infancy KG + DL
7 obsessive-compulsive disorder KG + DL
8 agoraphobia KG + DL
9 schizotypal personality disorder KG + DL
10 paranoid personality disorder KG + DL
11 schizoid personality disorder KG + DL
12 histrionic personality disorder (disease) KG + DL
13 migraine with brainstem aura KG + DL
14 migraine disorder KG + DL
15 trichotillomania KG + DL
16 manic bipolar affective disorder KG + DL
17 phobic disorder KG + DL
18 Tourette syndrome KG + DL
19 dependent personality disorder KG + DL
20 transient tic disorder KG + DL
21 narcissistic personality disorder KG + DL
22 mixed anxiety and depressive disorder KG + DL
23 insomnia (disease) KG + DL
24 myofascial pain syndrome KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.